Nebraska’s Medical Marijuana Journey: What’s Next After the Ballot Initiative?
In November, 71% of Nebraska voters supported legalizing medical cannabis, but the journey to making it a reality has been slow and contentious. The state legislature did not pass a bill this session, and the governor’s two appointees to the Medical Cannabis Commission have faced criticism. Despite the challenges, the commission is working to establish a framework for treatment, and patients are still seeking access to medical cannabis.
Currently, it is nearly impossible for Nebraskans to access medical cannabis without crossing state lines, as the regulatory system is not yet in place. The Medical Cannabis Commission is charged with creating application criteria for potential providers by July 1 and must start accepting eligible applications by October 1. However, the commission’s progress has been hindered by the attorney general’s lawsuit alleging fraud in the signature collection process.
The ballot initiative allows for the possession of up to 5 ounces of medical cannabis, but the regulations on what forms of cannabis are allowed are still unclear. Smoking, in particular, has been a point of contention, with some lawmakers and medical professionals expressing concerns about its health risks. The Nebraska Medical Association has not provided guidance to its members on medical cannabis, citing the need for formal infrastructure and additional guidance from regulators.
Despite the challenges, some companies are already preparing to enter the medical cannabis market in Nebraska. Brett Mayo, chief extraction and marketing officer at Sweetwater Hemp Company, said the company is hopeful to expand into the medical cannabis space once regulations are in place. Mayo emphasized the importance of consulting with industry professionals and reserving licenses or giving preferences to operations in Nebraska.
The commission’s first meeting was a positive step forward, with commissioners agreeing to work with the Department of Health and Human Services to draft regulations. The public will have an opportunity to provide feedback on the draft regulations at the commission’s next meeting on June 26.
Ultimately, the success of Nebraska’s medical cannabis program will depend on the commission’s ability to establish a clear and effective regulatory framework. Patients and advocates are eager to see progress, and the commission’s next steps will be closely watched.
